HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity.

Abstract
The ability to discriminate between primary Toxoplasma gondii infection acquired in early pregnancy and infection that occurred prior to pregnancy was assessed by an enzyme immunoassay (EIA) to determine the avidity of toxoplasma-specific immunoglobulin G (IgG). The results were compared to those of the Platelia Toxo-IgM EIA and the dye test. The mean IgG avidity of 73 serum samples collected within 20 weeks after the estimated time of infection was 5.9%. Among 26 serum samples showing latent infection (toxoplasma-specific IgG positive and IgM negative) and 56 IgM-positive serum samples with a low dye test titer (<300 IU/ml), the mean avidities were 51.3 and 57.5%, respectively. A total of 72.8% of 92 IgM-positive serum samples with a high dye test titer (>300 IU/ml), suggesting a recent toxoplasma infection, had an IgG avidity of >20%, indicating that the infection started more than 20 weeks earlier. By introducing high IgG avidity as a criterion in the first half of pregnancy to exclude the possibility that toxoplasma infection was acquired during gestation, many women will avoid unnecessary examinations, treatment, and anxiety.
AuthorsP A Jenum, B Stray-Pedersen, A G Gundersen
JournalJournal of clinical microbiology (J Clin Microbiol) Vol. 35 Issue 8 Pg. 1972-7 (Aug 1997) ISSN: 0095-1137 [Print] United States
PMID9230365 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Protozoan
  • Immunoglobulin G
Topics
  • Animals
  • Antibodies, Protozoan (immunology)
  • Antibody Affinity
  • Antibody Specificity
  • Female
  • Humans
  • Immunoglobulin G (immunology)
  • Pregnancy
  • Pregnancy Complications, Parasitic (diagnosis, immunology)
  • Toxoplasma (immunology)
  • Toxoplasmosis (diagnosis, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: